{
    "clinical_study": {
        "@rank": "125943", 
        "arm_group": {
            "arm_group_label": "Physical activity counseling", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the feasibility and effect of a program including\n      information, counseling and an individualized physical activity program on physical and\n      psychological health during and after chemotherapy in patients with testicular cancer. It is\n      hypothesized that the patients are able to complete the intervention with individual\n      adjustments."
        }, 
        "brief_title": "Physical Activity and Testicular Cancer", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Testicular Cancer", 
        "condition_browse": {
            "mesh_term": "Testicular Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Seminoma/non-seminoma\n\n          -  Stage II-IV\n\n          -  3-4 BEP(bleomycin,etoposide and cisplatin)or 4 EP(etoposide and cisplatin)\n\n          -  > 18 years\n\n          -  Capable of reading and writing Norwegian\n\n        Exclusion Criteria:\n\n          -  Conditions of a severity that contraindicate exercise without adjusted actions\n\n          -  Mentally incompetent conditions\n\n          -  Conditions of a severity that complicates the ability to participate in a supervised\n             training program"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01749774", 
            "org_study_id": "2011/2008a"
        }, 
        "intervention": {
            "arm_group_label": "Physical activity counseling", 
            "intervention_name": "Physical activity counseling", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Physical activity", 
            "Testicular cancer", 
            "Chemotherapy", 
            "Feasibility"
        ], 
        "lastchanged_date": "December 12, 2012", 
        "location": {
            "contact": {
                "email": "LKA@ous-hf.no", 
                "last_name": "Lene Thorsen, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Oslo", 
                    "country": "Norway"
                }, 
                "name": "Oslo university hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Norway"
        }, 
        "number_of_arms": "1", 
        "official_title": "Physical Activity and Testicular Cancer - a Pilot Study: Feasibility and Effects of a Program Including Information, Counseling and a Physical Activity Program for Patients With Testicular Cancer During and After Chemotherapy", 
        "overall_contact": {
            "email": "LKA@ous-hf.no", 
            "last_name": "Lene Thorsen, PhD", 
            "phone": "004722934000"
        }, 
        "overall_contact_backup": {
            "email": "jonlog@ous-hf.no", 
            "last_name": "Jon H\u00e5vard Loge, Prof.", 
            "phone": "004722934000"
        }, 
        "overall_official": {
            "affiliation": "Oslo universty hospital", 
            "last_name": "Lene Thorsen, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Norway:National Committee for Medical and Health Research Ethics", 
                "Norway: Directorate of Health"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in 1RM from baseline to post-intervention and follow-up", 
            "measure": "Muscle strength, 1RM (one-repetition-maximum)", 
            "safety_issue": "No", 
            "time_frame": "Baseline (0 weeks), post-intervention (9-12 weeks) and follow-up (24 weeks)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01749774"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Oslo University Hospital", 
            "investigator_full_name": "Lene Thorsen", 
            "investigator_title": "PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Change in VO2max from baseline to post-intervention and follow-up", 
                "measure": "Cardio respiratory fitness (VO2max)", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in body composition from baseline to post-intervention and follow-up", 
                "measure": "Body composition (Lean body mass and fat mass)", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in metabolic disease markers from baseline to post-intervention and follow-up", 
                "measure": "Metabolic disease markers (blood pressure, body mass index, glucose, high density lipoprotein cholesterol, triglycerides)", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in CRP from baseline to post-intervention and follow-up", 
                "measure": "C-reactive protein (CRP)", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in CK from baseline to post-intervention and follow-up", 
                "measure": "Creatinkinase (CK)", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in CK-MB from baseline to post-intervention and follow-up", 
                "measure": "Creatinkinase - MB (CK-MB)", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in myoglobin from baseline to post-intervention and follow-up", 
                "measure": "Myoglobin", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in work status from baseline to post-intervention and follow-up", 
                "measure": "Work status", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in fatigue from baseline to post-intervention and follow-up", 
                "measure": "Fatigue", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in anxiety and depression from baseline to post-intervention and follow-up", 
                "measure": "Anxiety and depression", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }, 
            {
                "description": "Change in quality of life from baseline to post-intervention and follow-up", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "Baseline (0 week), post-intervention (9-12 weeks) and follow-up (24 weeks)"
            }
        ], 
        "source": "Oslo University Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Norwegian School of Sport Sciences", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Aktiv against cancer", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Gjensidigestiftelsen", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "The Research Council of Norway", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Oslo University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}